The Global Virus Network: Challenging chikungunya

Edward McSweegan, Scott Weaver, Marc Lecuit, Matthew Frieman, Thomas E. Morrison, Sharon Hrynkow

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Abstract The recent spread of chikungunya virus to the Western Hemisphere, together with the ongoing Ebola epidemic in West Africa, have highlighted the importance of international collaboration in the detection and management of disease outbreaks. In response to this need, the Global Virus Network (GVN) was formed in 2011. The GVN is a coalition of leading medical virologists in 34 affiliated laboratories in 24 countries, who collaborate to share their resources and expertise. The GVN supports research, promotes training for young scientists, serves as a technical resource for governments, businesses and international organizations, facilitates international scientific cooperation, and advocates for funding and evidence-based public policies. In response to the spread of chikungunya, the GVN formed a task force to identify research gaps and opportunities, including models of infection and disease, candidate vaccines and antivirals, epidemiology and vector control measures. Its members also serve as authoritative sources of information for the public, press, and policy-makers. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World".

Original languageEnglish (US)
Article number3643
Pages (from-to)147-152
Number of pages6
JournalAntiviral Research
Volume120
DOIs
StatePublished - Jun 23 2015
Externally publishedYes

Keywords

  • Arbovirus
  • Chikungunya
  • Emerging virus
  • Global Virus Network
  • Vector-borne

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Fingerprint Dive into the research topics of 'The Global Virus Network: Challenging chikungunya'. Together they form a unique fingerprint.

  • Cite this

    McSweegan, E., Weaver, S., Lecuit, M., Frieman, M., Morrison, T. E., & Hrynkow, S. (2015). The Global Virus Network: Challenging chikungunya. Antiviral Research, 120, 147-152. [3643]. https://doi.org/10.1016/j.antiviral.2015.06.003